Home > Insider Trading > Pfizer Inc

Pfizer Inc (PFE)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
821 - 830
Next >>

Kinder Morgan Inc (KMI), Pfizer Inc. (PFE): Want to Be a Great Investor? Maybe You Should Have Been an English Major

I recently read Robert Hagstrom's "Investing: The Last Liberal Art", a tome that has some fascinating insights for any investor. The book is full of wisdom from Charlie Munger, longtime investing partner...

Keep Reading →

June 24th, 2013 - News

Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple

Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.

Keep Reading →

June 19th, 2013 - News

Merck & Co., Inc. (MRK), Zoetis Inc (ZTS), Kellogg Company (K) - Shorts Are Piling Into These Stocks. Should You Be Worried?

The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.

Keep Reading →

June 19th, 2013 - News

Actavis Inc (ACT), AbbVie Inc (ABBV): "Pay-For Delay" Was Fun While It Lasted

When the FTC and the U.S. Supreme Court start breathing down your neck it’s not a pleasant thing, and could become very expensive for certain companies.

Keep Reading →

June 18th, 2013 - News

Myriad Genetics, Inc. (MYGN): Big Pharma's Intellectual Property Blues

It’s not easy being a biotech company. Every year, the biotech industry pours billions of dollars in research and development costs towards creating cutting edge drugs that treat major diseases.

Keep Reading →

June 18th, 2013 - News

Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Top Treatments for High Cholesterol

About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease Control and Prevention...

Keep Reading →

June 18th, 2013 - News

Abbott Loves Abbott Laboratories (ABT) Stock

Abbott Laboratories (NYSE:ABT) seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.

Keep Reading →

June 18th, 2013 - News

Amgen, Inc. (AMGN): Huge Upside on Pipeline Strength

Amgen, Inc. (NASDAQ:AMGN) is the world’s largest independent biotechnology company.

Keep Reading →

June 18th, 2013 - News

Gilead Sciences, Inc. (GILD), American International Group, Inc. (AIG): The Biggest Companies That Don't Pay Dividends -- But May Be About To

The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.

Keep Reading →

June 17th, 2013 - Stock Analysis

Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): These 2 Healthcare Stocks Could Win Big With FDA's New 'Breakthrough' Status

To create a faster path to commercialization for potentially life-saving drugs and medicine, the FDA in July introduced a new "breakthrough" status for drugs that show "substantial improvement on existing...

Keep Reading →

June 17th, 2013 - Stock Analysis